Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kriván, Gergely
KIDCARES10, NCT04944979 / 2020-001496-32: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients	Recruiting	3	30	Europe, US, RoW	Kedrion IVIG 10%	Kedrion S.p.A., Pharmaceutical company, KEDRION S.p.A, Kedrion S.p.A	Primary Immunodeficiency Disease	04/26	10/26
Norwood, Tracy
KIDCARES10, NCT04944979 / 2020-001496-32: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients	Recruiting	3	30	Europe, US, RoW	Kedrion IVIG 10%	Kedrion S.p.A., Pharmaceutical company, KEDRION S.p.A, Kedrion S.p.A	Primary Immunodeficiency Disease	04/26	10/26
WEB PAS, NCT04839705: Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device	Recruiting	N/A	180	US	WEB	Microvention-Terumo, Inc.	Wide Neck Bifurcation Intracranial Aneurysms	12/25	12/29
Camacho, Juanita Valdes
KIDCARES10, NCT04944979 / 2020-001496-32: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients	Recruiting	3	30	Europe, US, RoW	Kedrion IVIG 10%	Kedrion S.p.A., Pharmaceutical company, KEDRION S.p.A, Kedrion S.p.A	Primary Immunodeficiency Disease	04/26	10/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kriván, Gergely
KIDCARES10, NCT04944979 / 2020-001496-32: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients	Recruiting	3	30	Europe, US, RoW	Kedrion IVIG 10%	Kedrion S.p.A., Pharmaceutical company, KEDRION S.p.A, Kedrion S.p.A	Primary Immunodeficiency Disease	04/26	10/26
Norwood, Tracy
KIDCARES10, NCT04944979 / 2020-001496-32: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients	Recruiting	3	30	Europe, US, RoW	Kedrion IVIG 10%	Kedrion S.p.A., Pharmaceutical company, KEDRION S.p.A, Kedrion S.p.A	Primary Immunodeficiency Disease	04/26	10/26
WEB PAS, NCT04839705: Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device	Recruiting	N/A	180	US	WEB	Microvention-Terumo, Inc.	Wide Neck Bifurcation Intracranial Aneurysms	12/25	12/29
Camacho, Juanita Valdes
KIDCARES10, NCT04944979 / 2020-001496-32: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients	Recruiting	3	30	Europe, US, RoW	Kedrion IVIG 10%	Kedrion S.p.A., Pharmaceutical company, KEDRION S.p.A, Kedrion S.p.A	Primary Immunodeficiency Disease	04/26	10/26